Dachaigh › Cancer briste triple-negative › Connecticut › New Haven
Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an New Haven, CT
Tha 15 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann agus timcheall air New Haven (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- Yale Cancer Center, New Haven
Study of AVZO-021 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A’ fastadhÌre 3
- Yale Cancer Center ( Site 0053), New Haven
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
A’ fastadh
- Yale University, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A’ fastadhÌre 1
- Yale University, Yale Cancer Center, New Haven
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
A’ fastadhÌre 2
- Yale Cancer Center Clinical Trials Office, New Haven
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Yale Cancer Center, New Haven
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1
- Yale Cancer Center, New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
A’ fastadhÌre 1
- Normunity Investigational Site, New Haven
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
A’ fastadhÌre 1
- Yale New Haven Hospital, New Haven
Saci Nivo Rela for TNBC
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
- Yale University, New Haven
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
A’ fastadhÌre 2
- Yale Cancer Center, New Haven
Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
A’ fastadh
- Yale University, New Haven
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
A’ fastadhÌre 1/2
- Yale Cancer Center, New Haven
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
A’ fastadhÌre 1/2
- Yale Cancer Center, New Haven
Sgrùdaidhean Cancer briste triple-negative ann am bailtean eile
- Houston, TX42 sgrùdaidhean
- New York City, NY31 sgrùdaidhean
- Nashville, TN28 sgrùdaidhean
- Los Angeles, CA27 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- San Antonio, TX23 sgrùdaidhean
- St. Louis, MO21 sgrùdaidhean
- Arlington, VA20 sgrùdaidhean
- Atlanta, GA20 sgrùdaidhean
- Dallas, TX18 sgrùdaidhean
- Chicago, IL16 sgrùdaidhean
- Columbus, OH16 sgrùdaidhean
Sgrùdaidhean eile ann an New Haven
- Aillse Sgamhain Neo-chealla-beag41 sgrùdaidhean
- Aillse a' bhroilleach38 sgrùdaidhean
- Aillse (gach seòrsa)33 sgrùdaidhean
- Ailse metastatach23 sgrùdaidhean
- Ailseachadh nan Sgamhan22 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil22 sgrùdaidhean
- Cancer Ovarian21 sgrùdaidhean
- Aillse colorectal20 sgrùdaidhean
- Aillse Prostata20 sgrùdaidhean
- Leukemia myeloid geur17 sgrùdaidhean
- Disorder of Alcohol Use (AUD)17 sgrùdaidhean
- Overdose Opioid17 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.